Answers are grounded in this paper and cite their sources.
Retrospective trial evaluates SPECT/CT to assess CLAD in lung transplant recipients, suggesting its diagnostic potential.
Background: Chronic lung allograft dysfunction (CLAD) is a major cause of late morbidity after lung transplantation, and spirometry lacks the ability to detect regional lung changes. Thus, in this study, we investigated whether quantitative perfusion single-photon emission CT/CT parameters can distinguish CLAD from non-CLAD lungs and how they relate to pulmonary function. Patients and Methods: This retrospective study included 80 lung transplant recipients who underwent SPECT/CT. Standardized uptake value (SUV) mean , total lung uptake (TLU), and percentage injected dose (%ID) were calculated, and group differences, receiver operating characteristic performance, and correlations with forced expiratory volume in 1 second, forced vital capacity, and total lung capacity were analyzed. Results: No significant difference was observed for SUV mean ( P = 0.250), whereas TLU and %ID were significantly lower in CLAD ( P < 0.0001). Area under the curve values were 0.56 (SUV mean ), 0.76 (TLU), and 0.78 (%ID). %ID showed the best accuracy (cutoff: 0.83; sensitivity: 65.0%; specificity: 83.8%). Conclusions: Volume-based metrics, especially %ID, serve as useful noninvasive indicators for the assessment of CLAD.
No takes yet. Share an insight, caveat, or question.
Nakashima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: